Home

Cisplatin in der Krebstherapie / Cisplatin in Cancer Therapy

18.3.2010

http://www.eurekalert.org/pub_releases/2010-03/uotm-rfn031710.php
Researchers find new chemotherapy combination shows promise in endometrial cancer
gemcitabine cisplatin

27.4.2009

http://www.eurekalert.org/pub_releases/2007-04/mgh-msm041207.php
Molecular signature may identify cisplatin-sensitive breast tumors
cisplatin HER2 p73 p63 BRCA1

7.10.2008

http://www.translational-medicine.com/content/6/1/55
Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin

14.11.2007

http://www.bionity.com/news/d/74117/?WT.mc_id=ca0067
Resistenz bei Chemotherapie: Wie sich Tumoren gegen den Wirkstoff Cisplatin wehren
DNA-Polymerase Chemotherapie

2.8.2008

http://web.mit.edu/newsoffice/2008/cancer-drug-0617.html
MIT finding could improve colon cancer treatment
cDPCP cisplatin

6.9.2008

http://www.upi.com/Health_News/2008/08/28/Protein_linked_to_chemo-drug_resistance/UPI-43231219977371/
Protein linked to chemo-drug resistance
cisplatin p73 PMS2

22.6.2008

http://www.biomedcentral.com/1471-2407/8/175
Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells

1.5.2008

http://www.news-medical.net/?id=37656
Cisplatin found to be less effective than standard treatment for patients with anal cancer

1.5.2008

http://www.newswise.com/articles/view/539936/?sc=rsmn
Experimental Therapy Not More Effective Than Standard Treatment For Anal Canal Cancer
cisplatin

1.5.2008

http://www.newswise.com/articles/view/539992/?sc=rsmn
Cisplatin Less Effective Than Standard Treatment for Patients With Anal Cancer

10.3.2008

http://www.molecular-cancer.com/content/7/1/24
Phenylbutyrate interferes with the Fanconi anemia and BRCA pathway and sensitizes head and neck cancer cells to cisplatin

6.1.2008

http://www.eurekalert.org/pub_releases/2007-04/joci-wck041207.php
Why cisplatin kills breast cancer cells when other drugs fail
HER2 delta-Np63 TAp73

14.11.2007

http://www.sciencemag.org/cgi/content/full/318/5852/967?rss=1
[REPORTS] Bypass of DNA Lesions Generated During Anticancer Treatment with Cisplatin by DNA Polymerase ?

1.11.2007

http://idw-online.de/pages/de/news233033
Wie kommt der Tumorwirkstoff zum Zellkern?
Cisplatin Kupfertransporter

9.11.2007

http://www.sciencemag.org/cgi/content/full/318/5852/967?rss=1
[REPORTS] Bypass of DNA Lesions Generated During Anticancer Treatment with Cisplatin by DNA Polymerase ?

9.11.2007

http://www.bionity.com/news/d/72945/?WT.mc_id=ca0067
Wie kommt der Tumorwirkstoff zum Zellkern?
Cisplatin

25.10.2007

http://www.molecular-cancer.com/content/6/1/66
Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin

7.6.2007

http://www.eurekalert.org/pub_releases/2007-06/jotn-im053007.php
Cisplatin is more effective than carboplatin for treating nonsmall cell lung cancer

17.5.2007

http://www.eurekalert.org/pub_releases/2007-05/obi-ddc050907.php
Dealing deadly cancers a knockout punch
Reovirus CISPLATIN

22.1.2009

http://7thspace.com/headlines/301472/inhibition_of_pi3k_increases_oxaliplatin_sensitivity_in_cholangiocarcinoma_cells.html
Inhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cells

22.1.2009

http://www.cancerci.com/content/9/1/3
Inhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cells
cholangiocarcinoma